uniQure N.V. (QURE) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, uniQure reported revenue of $16.1M, down 40.6% from $27.1M the year before. Net income was -$199.0M (a -1236.0% net margin), or -$3.46 per diluted share. Gross margin was 89.5% and operating margin was -1151.4%. Operating activities generated -$178.0M of cash, leaving -$178.4M of free cash flow. At fiscal year end, uniQure held $824.9M in total assets against $626.0M in total liabilities, including $80.2M of cash and equivalents.
Open the full interactive uniQure financials → Quarterly statements, key ratios, valuation history and price charts.
uniQure Key Stats
| Share Price | $21.28 |
|---|---|
| Market Cap | $1.41B |
| Revenue YoY Growth | -40.6% |
| 52-Week Range | $9.03 – $70.59 |
| Shares Outstanding | 66.2 million (basic, 2026 Q2) |
uniQure Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $37.5M | $524.0M | $106.5M | $15.8M | $27.1M | $16.1M |
| Cost of Goods Sold | $2.9M | $25.0M | $1.3M | $65,000 | $1.3M | $1.7M |
| Gross Profit | $34.6M | $499.0M | $105.2M | $15.8M | $25.9M | $14.4M |
| Operating Income | -$125.4M | $310.6M | -$143.2M | -$282.9M | -$184.3M | -$185.3M |
| Pre-Tax Income | -$141.4M | $332.8M | -$128.3M | -$306.6M | -$237.1M | -$193.3M |
| Income Tax | -$16.4M | $3.2M | -$1.5M | $1.9M | $2.4M | $5.6M |
| Net Income | -$125.0M | $329.6M | -$126.8M | -$308.5M | -$239.6M | -$199.0M |
| Diluted EPS | -$2.81 | $7.04 | -$2.71 | -$6.47 | -$4.92 | -$3.46 |
uniQure Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $3.7M | $5.6M | $3.6M | $5.8M |
| Net Income | -$80.5M | -$37.1M | -$53.5M | -$81.1M |
| Diluted EPS | -$1.38 | -$0.64 | -$0.85 | -$1.22 |
uniQure Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $244.9M | $556.3M | $228.0M | $241.4M | $158.9M | $80.2M |
| Current Assets | $258.9M | $628.2M | $476.8M | $651.9M | $390.3M | $656.0M |
| Total Assets | $340.4M | $809.2M | $705.0M | $831.7M | $556.5M | $824.9M |
| Current Liabilities | $27.3M | $36.8M | $75.9M | $73.7M | $40.1M | $62.9M |
| Total Long-Term Debt | $42.4M | $135.6M | $144.5M | $147.6M | $66.0M | $71.9M |
| Total Liabilities | $96.5M | $213.4M | $229.0M | $624.0M | $563.3M | $626.0M |
| Shareholders' Equity | $243.9M | $595.8M | $476.0M | $207.7M | -$6.8M | $198.9M |
uniQure Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$134.8M | $288.0M | -$145.1M | -$145.9M | -$182.7M | -$178.0M |
| Cash From Investing | -$9.5M | -$67.4M | -$182.7M | -$205.7M | $163.0M | -$321.6M |
| Cash From Financing | $7.4M | $94.9M | $1.4M | $362.7M | -$59.5M | $415.4M |
| Free Cash Flow | -$142.1M | $270.5M | -$162.7M | -$153.1M | -$186.1M | -$178.4M |
Figures from uniQure's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full uniQure financials page for every line item.
uniQure Company Profile
| Ticker | QURE |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Amsterdam |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001590560 |
Frequently Asked Questions
What was uniQure's revenue in fiscal 2025?
uniQure (QURE) reported revenue of $16.1M for fiscal 2025.
What is uniQure's annual revenue history?
uniQure's annual revenue by fiscal year: 2020: $37.5M; 2021: $524.0M; 2022: $106.5M; 2023: $15.8M; 2024: $27.1M; 2025: $16.1M.
What was uniQure's net income in fiscal 2025?
uniQure reported net income of -$199.0M for fiscal 2025.
What was uniQure's earnings per share (EPS) in fiscal 2025?
uniQure's diluted EPS was -$3.46 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did uniQure generate in fiscal 2025?
uniQure generated -$178.4M of free cash flow in fiscal 2025.
What was uniQure's revenue last quarter?
In its most recent reported quarter (2026 Q2), uniQure reported revenue of $5.8M.
How much debt does uniQure have?
uniQure reported $71.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of uniQure are outstanding?
uniQure reported a weighted average of 66.2 million basic shares outstanding in 2026 Q2.
What is uniQure's market cap?
Based on its latest closing price, uniQure (QURE) has a market capitalization of about $1.41B.
When does uniQure's fiscal year end?
uniQure's fiscal year end, as registered with the SEC, is December 31.
Where is uniQure headquartered?
uniQure lists its business address in Amsterdam in its SEC filings.